A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer
We described a case of BP that developed 2.5 years after the administration of nivolumab for metastatic non‐small cell lung cancer. Our report highlights the fact that dermatologists should be aware of anti PD‐1‐related BP, which can appear very late during treatment.
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c13686787fc34df6b290fef44c1c5e16 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c13686787fc34df6b290fef44c1c5e16 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c13686787fc34df6b290fef44c1c5e162021-12-02T09:08:29ZA case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer2574-459310.1002/cia2.12189https://doaj.org/article/c13686787fc34df6b290fef44c1c5e162021-12-01T00:00:00Zhttps://doi.org/10.1002/cia2.12189https://doaj.org/toc/2574-4593We described a case of BP that developed 2.5 years after the administration of nivolumab for metastatic non‐small cell lung cancer. Our report highlights the fact that dermatologists should be aware of anti PD‐1‐related BP, which can appear very late during treatment.Emi YokoyamaOsamu YamasakiToshio KuboHiroshi KogaNorito IshiiShin MorizaneWileyarticleDermatologyRL1-803Immunologic diseases. AllergyRC581-607ENJournal of Cutaneous Immunology and Allergy, Vol 4, Iss 6, Pp 170-172 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Dermatology RL1-803 Immunologic diseases. Allergy RC581-607 |
| spellingShingle |
Dermatology RL1-803 Immunologic diseases. Allergy RC581-607 Emi Yokoyama Osamu Yamasaki Toshio Kubo Hiroshi Koga Norito Ishii Shin Morizane A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer |
| description |
We described a case of BP that developed 2.5 years after the administration of nivolumab for metastatic non‐small cell lung cancer. Our report highlights the fact that dermatologists should be aware of anti PD‐1‐related BP, which can appear very late during treatment. |
| format |
article |
| author |
Emi Yokoyama Osamu Yamasaki Toshio Kubo Hiroshi Koga Norito Ishii Shin Morizane |
| author_facet |
Emi Yokoyama Osamu Yamasaki Toshio Kubo Hiroshi Koga Norito Ishii Shin Morizane |
| author_sort |
Emi Yokoyama |
| title |
A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer |
| title_short |
A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer |
| title_full |
A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer |
| title_fullStr |
A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer |
| title_full_unstemmed |
A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer |
| title_sort |
case of bullous pemphigoid after a long‐term administration of anti‐pd‐1 antibodies in a patient with non‐small‐cell lung cancer |
| publisher |
Wiley |
| publishDate |
2021 |
| url |
https://doaj.org/article/c13686787fc34df6b290fef44c1c5e16 |
| work_keys_str_mv |
AT emiyokoyama acaseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT osamuyamasaki acaseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT toshiokubo acaseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT hiroshikoga acaseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT noritoishii acaseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT shinmorizane acaseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT emiyokoyama caseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT osamuyamasaki caseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT toshiokubo caseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT hiroshikoga caseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT noritoishii caseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer AT shinmorizane caseofbullouspemphigoidafteralongtermadministrationofantipd1antibodiesinapatientwithnonsmallcelllungcancer |
| _version_ |
1718398269355196416 |